Transcriptome changes in stages of non-alcoholic fatty liver disease

doi:10.4254/wjh.v14.i7.1382

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4922)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

205

WORD

HTML

2650

Figures (1-5)

372

Tables (1-4)

263

Sum=3516

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

231

Download

393

Sum=624

Publishing Process of This Article

Item

Count

Browse

326

Download

456

Sum=782

Jul 27, 2022 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Hepatol. Jul 27, 2022; 14(7): 1382-1397
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1382

Full Size Figure Download Figure

Figure 3 Ingenuity Pathway Analysis of SREBF1 signaling in non-alcoholic fatty liver disease. Genes are implicated in several potential disease processes including the inflammation, metabolism, and transport. Legend illustrates relationship between genes. See Figure 2 legend for identification of shapes. Figure generated using Ingenuity Pathway Analysis.

Citation: Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, Hadley D, Spengler R, Spengler E. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1382-1397
URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1382.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1382